News Breaks |
|
|
| September 28, 2012 |
| 10:28 EDT |  | MDT, KH | Medtronic acquisition makes strategic sense, says Piper Jaffray
Piper Jaffray believes Medtronic's (MDT) acquisition of China Kanghui Holdings (KH) makes solid strategic sense since it opens for the company larger sales opportunities in the Eastern hemisphere. Piper keeps an Overweight rating and $45 price target on shares of Medtronic. |
|
|
News For MDT;KH From The Last 14 Days Check below for free stories on MDT;KH the last two weeks. |
|
|
| May 16, 2013 |
| 13:32 EDT |  | MDT | Medtronic volatility flat into Q4 and outlook
 Subscribe for More Information |
|
| 10:03 EDT |  | MDT | On The Fly: Analyst Downgrade Summary
Subscribe for More Information |
|
| 06:32 EDT | | MDT | Medtronic downgraded to Neutral from Outperform at Credit Suisse
Subscribe for More Information |
|
| May 10, 2013 |
| 15:49 EDT |  | MDT | Medtronic defibrillators demonstrate success of shock avoidance
Subscribe for More Information |
|
| May 8, 2013 |
| 07:38 EDT |  | MDT | BofA/Merrill's medical tech analyst hold an analyst/industry conference call
Subscribe for More Information |
|
| May 6, 2013 |
| 09:19 EDT | | MDT | Medtronic receives FDA approval for newest cardiac devices
Medtronic announced FDA approval and U.S. launch of its newest cardiac devices: the Viva portfolio of cardiac resynchronization therapy with defibrillation, or CRT-D, devices, and the Evera portfolio of implantable cardioverter-defibrillators. |
|
|
|
|
|
